ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Ms. Yuki is suffering from cancer.

Patient basic information Patient: Ms. Yuki (Yuki Sanchez) Nationality: Latvia Diagnosis: Pancreatic Cancer Diagnostic Hospital: H0ZN Treatment Program: Targeted Treatment + Immunotherapy Housing days: 111 days Treatment cost: approximately 634978 yuan Treatment effect: Complete relief The patient is from Latvia and was diagnosed with pancreatic cancer locally. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, guidance and on-site services throughout the treatment process.

The MD2 team used a comprehensive set of targeted therapeutic+immunotherapies, with the medical team closely monitoring the patient's indicators and dynamic adjustment programs during the treatment process. After 111 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas and successfully reached the hospital standard. The treatment effect was finally completely relaxed.

When the patient was discharged, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to monitor the recovery through the remote follow-up system. 'Mrs. Liu Yuki's experts have criticized the case as a typical case of cross-border suspected seriousness clinical cases.

Liu4 is a multidisciplinary collaborative mechanism that has developed targeted treatment+immunotherapy programs for pancreatic cancer, reflecting the comprehensive strength of Chinese hospitals in the field of suspected diagnostics and a summary of how international medical services are regulated. (Figure from Liu5 official news reports and medical scenarios)

拉脱维亚,胰腺癌,北京大学人民医院,国际医疗,来华就医,中国医疗